✦ LIBER ✦

P101 Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer

✍ Scribed by M. Gallén; C. Alonso; B. Ojeda; P. Viladiu; M. Beltrán; J. Borras; A. Pelegri; I. Tusquets; A. Barnadas; A. Arcusa; R. Bastús; A. Balil; E. Batiste-Alentom; M. Boleda; M.A. Badia; I. Garau; I. Guash

Book ID: 117665536
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 157 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89318-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P79 Randomized Comparison of Adjuvant To

P79 Randomized Comparison of Adjuvant Toremifene (Tor) Versus Tamoxifen (Tam) for Postmenopausal Women with Node-Positive (N+), Estrogen Receptor-Positive (ER+) Early Stage Breast Cancer

✍ O. Pagani; S. Gelber; E. Simoncini; S. Holmberg; M. Colleoni; D. Crivellari; S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Randomized trial of two versus five year

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: Swedish Breast Cancer Cooperative Group J Natl Cancer Inst 1996:88:1543-49

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 224 KB

Randomised trial of two versus five year

Randomised trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: preliminary results of the SITAM-01

✍ M. Sacco; M. Valentini; M. Belfiglio; A. Nicolucci; F. Pellegrini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Chemotherapy versus tamoxifen versus che

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial

✍ Boccardo, F.; Rubagotti, A.; Amoroso, D.; Sismondi, P.; Genta, F.; Nenci, I.; Pi 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Randomized trial to evaluate the additio

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

✍ James N. Ingle; Lloyd K. Everson; H. Sam Wieand; Stephen A. Cullinan; Lester E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

1–42 A Randomized Trial of Exemestane Af

1–42 A Randomized Trial of Exemestane After Two to Three Years of Tamoxifen Therapy in Postmenopausal Women With Primary Breast Cancer

✍ Buzdar, A.U. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB